Immunotherapy for Head and Neck Cancer Treatment
1 意见
• 07/02/23
0
0
嵌入
Head and neck cancer and skull base surgeon Nyall London discusses immunotherapy clinical trials that have contributed to FDA approval for nivolumab and pembrolizumab for recurrent head and neck squamous cell carcinoma. https://hopkinsmedicine.org/oto #HeadandNeckCancerTreatment #JohnsHopkins
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论